Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine FNB vs CFNC in Total Knee Replacement
NCT02106481Completed
- Sponsor
- Northern Light Eastern Maine Medical Center
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, triple-blind trial of ropivacaine hydrochloride liposomal suspension injection in knee osteoarthritis (OA), sponsored by Northern Light Eastern Maine Medical Center. Primary endpoint: Pain Visual Analogue Score at 48 hours. Started Apr 2014; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02106481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106481.